AAAAAA

   
Results: 1-17 |
Results: 17
Long-term risk stratification for survivors of acute coronary syndromes - Results from the long-term intervention with pravastatin in ischemic disease (LIPID) study
Authors: Marschner, IC Colquhoun, D Simes, RJ Glasziou, P Harris, P Singh, BB Friedlander, D White, H Thompson, P Tonkin, A
Citation: Ic. Marschner et al., Long-term risk stratification for survivors of acute coronary syndromes - Results from the long-term intervention with pravastatin in ischemic disease (LIPID) study, J AM COL C, 38(1), 2001, pp. 56-63
Combining components of quality of life to increase precision and evaluatetrade-offs
Authors: Lumley, T Simes, RJ Gebski, V Hudson, HM
Citation: T. Lumley et al., Combining components of quality of life to increase precision and evaluatetrade-offs, STAT MED, 20(21), 2001, pp. 3231-3249
Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial
Authors: White, HD Simes, RJ Aylward, PEG Armstrong, PW Califf, RM French, JK Granger, CB Marschner, IC Topol, EJ Van de Werf, FJ Wilcox, RG
Citation: Hd. White et al., Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial, LANCET, 358(9296), 2001, pp. 1855-1863
Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial
Authors: Toner, GC Stockler, MR Boyer, MJ Jones, M Thomson, DB Harvey, VJ Olver, IN Dhillon, H McMullen, A Gebski, VJ Levi, JA Simes, RJ
Citation: Gc. Toner et al., Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial, LANCET, 357(9258), 2001, pp. 739-745
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
Authors: Stockler, M Wilcken, NRC Ghersi, D Simes, RJ
Citation: M. Stockler et al., Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer, CANC TR REV, 26(3), 2000, pp. 151-168
A comparison of standard gamble, time trade-off, and adjusted time trade-off scores
Authors: Martin, AJ Glasziou, PP Simes, RJ Lumley, T
Citation: Aj. Martin et al., A comparison of standard gamble, time trade-off, and adjusted time trade-off scores, INT J TE A, 16(1), 2000, pp. 137-147
Effects of pravastatin in 3260 patients with unstable angina: results fromthe LIPID study
Authors: Tonkin, AM Colquhoun, D Emberson, J Hague, W Keech, A Lane, G MacMahon, S Shaw, J Simes, RJ Thompson, PL White, HD Hunt, D
Citation: Am. Tonkin et al., Effects of pravastatin in 3260 patients with unstable angina: results fromthe LIPID study, LANCET, 356(9245), 2000, pp. 1871-1875
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial
Authors: Topol, CE Califf, RM Simes, RJ Van de Werf, F Diaz, R Paolasso, E Aylward, PE Keech, A Klein, W Piegas, L Tomov, I Armstrong, PW Widimsky, P Grande, P Halinen, M Vahanian, A Neuhaus, K Dimas, AP Preda, I Kristinsson, A Tzivoni, D Ardissino, D White, HD Madsen, S Sugrue, D Sadowski, Z Seabra-Gomes, R Apetrei, E Dalby, A Betriu, A Pfisterer, M Verheugt, F Fox, K Bates, ER Gibler, WB Granger, CB Harrington, RA Hochman, JS Holmes, DR Kleiman, NS Lee, KL Moliterno, DJ Newby, LK Ohman, EM Califf, R Newby, K Zillman, L Lee, K Lemons, P McCourt, B Campbell, C Tardiff, B Snapp, J Bassett, K Hodgson, P Hannan, K Kandzari, L Hawkins, S Hinman-Smith, E McDougal, M Raffetto, K Thompson, D Wehrle, T Ange, C Brown, R Grissom, G Heuckel, M McCall, J Pennachi, W Spychala, M Veasey, S Pullium, M Journey, T Quintero, K Mark, D Davidson-Ray, L Diner, L Nelson, C Sowers, C Webb, G Young, M Bhapkar, M Pacchiana, C Sparapani, R Tuttle, R Weaver, D Borzak, S Douthat, L Topol, E Moliterno, D Konczos, L Baishnab, R Baishnab, R Bakos, A Blashford, L Bratsch, J Brown, K Cadorini, E Carlson, J Clemmons, P DelValle, M Drabik, M Fu, G Gates, K Gibson, Y Heil, L Hill, N Klancar, R McHale, B Montague, E Pasca, N Pergi, L Randall, R Rosso, R Sankovich, K Smith, D Wisniewski, L Witkowski, M Zovkic, V Alexander, K Bhatt, D Brener, S Campbell, L Cho, L Cole, C Deedy, M Foody, J Gassler, J Ghaffari, S Haas, G Kapadia, S Lauer, M Lauer, MS Lincoff, M Lutton, S Marso, S Mukherjee, D Patel, V Penn, M Robbins, M Roe, M Sila, C Thamilarasan, M Wagner, G Armstrong, P Bestilny, S Van de Werf, F Budts, W Graux, S Luyten, A Simes, J Keech, A Kava, M Bower, T Chan, S Crampton, L Monro, C Nayak, M Parente, G Riley, V Wilton, D Aylward, P Dolan, S Thomas, C White, H Scott, M Frye, R Alpert, J Bertrand, M Ryan, T Fisher, L Asarch, L Smith, M Lim, L Bokslag, M Chiu, P Chung, J Collins, S Dougherty, C Guimaraes, D Hakim, Z Mathieson, J Montgomery, L Novotny, B Steiner, B Wittke, B
Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345
Pravastatin therapy and the risk of stroke.
Authors: White, HD Simes, RJ Anderson, NE Hankey, GJ Watson, JDG Hunt, D Colquhoun, DM Glasziou, P MacMahon, S Kirby, AC West, MJ Tonkin, AM
Citation: Hd. White et al., Pravastatin therapy and the risk of stroke., N ENG J MED, 343(5), 2000, pp. 317-326
Pravastatin therapy and the risk of stroke. Reply
Authors: White, HD Simes, RJ Tonkin, AM
Citation: Hd. White et al., Pravastatin therapy and the risk of stroke. Reply, N ENG J MED, 343(25), 2000, pp. 1895-1896
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial
Authors: Califf, RM Pieper, KS Lee, KL Van de Werf, F Simes, RJ Armstrong, PW Topol, EJ
Citation: Rm. Califf et al., Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial, CIRCULATION, 101(19), 2000, pp. 2231-2238
Doctors' participation in randomized trials of adjuvant systemic therapy in breast cancer: how does it relate to their recommendations for standard therapy in breast cancer?
Authors: Ellis, PM Butow, PN Simes, RJ Tattersall, MHN Dunn, SM MacLeod, C
Citation: Pm. Ellis et al., Doctors' participation in randomized trials of adjuvant systemic therapy in breast cancer: how does it relate to their recommendations for standard therapy in breast cancer?, BREAST, 8(4), 1999, pp. 182-187
A cardiovascular extension of the Health Measurement Questionnaire
Authors: Martin, AJ Glasziou, PP Simes, RJ
Citation: Aj. Martin et al., A cardiovascular extension of the Health Measurement Questionnaire, J EPIDEM C, 53(9), 1999, pp. 548-557
Pravastatin and coronary heart disease - Reply
Authors: Tonkin, A Hunt, D Simes, RJ
Citation: A. Tonkin et al., Pravastatin and coronary heart disease - Reply, N ENG J MED, 340(14), 1999, pp. 1116-1117
Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists
Authors: Ellis, PM Butow, PN Simes, RJ Tattersall, MHN Dunn, SM
Citation: Pm. Ellis et al., Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists, AUST NZ J S, 69(7), 1999, pp. 486-491
Support for the open-artery hypothesis in survivors of acute myocardial infarction: Analysis of 11,228 patients treated with thrombolytic therapy
Authors: Puma, JA Sketch, MH Thompson, TD Simes, RJ Morris, DC White, HD Topol, EJ Califf, RM
Citation: Ja. Puma et al., Support for the open-artery hypothesis in survivors of acute myocardial infarction: Analysis of 11,228 patients treated with thrombolytic therapy, AM J CARD, 83(4), 1999, pp. 482-487
Predicting patients' utilities from quality of life items: an improved scoring system for the UBQ-H
Authors: Martin, AJ Glasziou, PP Simes, RJ Lumley, T
Citation: Aj. Martin et al., Predicting patients' utilities from quality of life items: an improved scoring system for the UBQ-H, QUAL LIFE R, 7(8), 1998, pp. 703-711
Risultati: 1-17 |